Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

10x Genomics, Inc. - Common Stock (NQ:TXG)

20.41 +1.12 (+5.81%)
Streaming Delayed Price Updated: 1:15 PM EST, Jan 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about 10x Genomics, Inc. - Common Stock

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
News headline image
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline ↗
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc... 
Via Benzinga
News headline image
Notable 10X Genomics Insider Trades $2.7M In Company Stock ↗
Bradford Crutchfield, Chief Commercial Officer at 10X Genomics (NASDAQ:TXG), made a large buy and sell of company shares on October 12, according to a new SEC filing. What... 
Via Benzinga
Topics Regulatory Compliance
News headline image
3 COVID Stocks That Can Turn $1,000 Into $10,000 ↗
Our trio of contributors offer three COVID-19 stocks that will zoom higher, even as we emerge from the pandemic. 
Via The Motley Fool
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For September 16, 2021 ↗
Upgrades For Signet Jewelers Ltd (NYSE: 
Via Benzinga
News headline image
Why 10x Genomics Shares Are Trading Lower Today ↗
10x Genomics (NASDAQ:TXG) shares are trading lower after B of A Securities downgraded the stock from Buy to Neutral and announced a $180 price target. 10x Genomics' stock... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 27) Bio-Rad Laboratories, Inc... 
Via Benzinga
News headline image
Recap: 10x Genomics Q1 Earnings ↗
Shares of 10x Genomics (NASDAQ:TXG) remained unaffected after the company reported Q1 results. Quarterly Results Earnings per share rose 186.96% over the past year to $0.66... 
Via Benzinga
News headline image
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge ↗
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For September 14, 2021 ↗
Upgrades Northcoast Research upgraded the previous rating for Casey's General Stores Inc ... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
Gainers Scopus BioPharma (NASDAQ:SCPS) s... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Orphazyme Falters At FDA, Athira's CEO Placed On Temporary Leave, 5 IPOs ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 17) 10x Genomics, Inc. (NASDAQ... 
Via Benzinga
News headline image
Earnings Scheduled For August 5, 2021 ↗
Companies Reporting Before The Bell • OneSpaWorld Holdings (NASDAQ:OSW) is projected to report quarterly loss at $0.20 per share on revenue of $6.42 million. •... 
Via Benzinga
News headline image
Earnings Scheduled For August 4, 2021 ↗
Companies Reporting Before The Bell • UroGen Pharma (NASDAQ:URGN) is projected to report earnings for its second quarter. • Vericel (NASDAQ:VCEL) is expected to... 
Via Benzinga
News headline image
The Daily Biotech Pulse: COVID Disappointments For Altimmune And Angion, Brickell Jumps On Hyperhidrosis Study Updates, 2 IPOs ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 29) 10x Genomics, Inc. (NASDAQ... 
Via Benzinga
News headline image
Here's Why 10x Genomics Can't Satisfy Short-Term Investors ↗
Long-term investors should keep perspective. 
Via The Motley Fool
News headline image
10x Genomics Stock Shows Rising Price Performance With Jump To 83 RS Rating ↗
On Friday, biotech 10x Genomics stock received an upgrade to its Relative Strength (RS) Rating to 83, from 80 on Thursday. 
Via Investor's Business Daily
News headline image
Stocks That Hit 52-Week Highs On Tuesday ↗
Tuesday's morning session saw 105 companies set new 52-week highs. Things to Consider: The largest company by market cap to break to a new 52-week high was... 
Via Benzinga
News headline image
Down More Than 20%, Is This Cathie Wood Biotech A Buy? ↗
10x Genomics stock has fallen, despite announcing strong first-quarter numbers. 
Via The Motley Fool
News headline image
These 7 Medical Stocks Are Breaking Down — The Sell Rule You Should Know ↗
Former high-flyers Dexcom and Tandem Diabetes are among seven health care stocks breaking down right now, according to MarketSmith.com. 
Via Investor's Business Daily
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
Gainers Lexaria Bioscience (NASDAQ:LEXX) shares rose 53.87% to $7.74 during Thursday's regular session. As of 12:30 EST, Lexaria Bioscience's stock is trading at a... 
Via Benzinga
News headline image
Why Investors Didn't Like 10x Genomics' Q1 Results ↗
The company delivered tremendous revenue growth but a deteriorating bottom line. 
Via The Motley Fool
News headline image
Earnings Scheduled For May 13, 2021 ↗
Companies Reporting Before The Bell • CASI Pharmaceuticals (NASDAQ:CASI) is estimated to report quarterly loss at $0.06 per share on revenue of $5.05 million. •... 
Via Benzinga
News headline image
Cathie Wood Cuts Apple Stake By 30% And Buys Coinbase, DraftKings ↗
Cathie Wood-led Ark Investment Management shed more shares of Apple Inc (NASDAQ: 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
Gainers Applied Genetic (NASDAQ:AGTC) sha... 
Via Benzinga
News headline image
72 Biggest Movers From Yesterday ↗
Gainers SemiLEDs Corporation (NASDAQ: LEDS) shares surged 85.8% to settle at $10.22 on above-average volume. Liquidity Services, Inc. (NASDAQ: LQDT) jumped 37.7% to settle at $25... 
Via Benzinga
News headline image
10x Genomics's Earnings: A Preview ↗
On Wednesday, May 05, 10x Genomics (NASDAQ:TXG) will release its latest earnings report. Benzinga's report can help you figure out the ins and outs of the earnings release. Net... 
Via Benzinga
News headline image
Cathie Wood Slashes Apple Stake To Half — Also Trims Google, Fastly: What You Need To Know ↗
Cathie Wood-led Ark Investment Management nearly halved the Apple Inc (NASDAQ: AAPL) stake in the ARK Fintech Innovation ETF (NYSE: ARKF) on Thursday. ARKF shed 298,505 Apple... 
Via Benzinga
News headline image
58 Stocks Moving In Thursday's Mid-Day Session ↗
Gainers Stealth BioTherapeutics Corp (NASDAQ: MITO) shares surged 92.9% to $2.3150. Stealth BioTherapeutics presented at the Association for Research in Vision and Ophthalmology... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 5) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 4) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.